DLA Piper has advised Perimed in connection with the strategic investment from Serendipity Partners

DLA Piper has advised Perimed AB ("Perimed"), a Swedish MedTech company and world leader in instruments for advanced vascular diagnostics, in connection with the strategic investment from Serendipity Partners, a leading Nordic healthcare growth investor. The strategic investment will fuel Perimed’s expansion plans, particularly in the United States.

Read the press release by Perimed here.